Eli Lilly's Covid-19 partner AbCellera pays $90M for some very special mice as IPO rumors heat up

AbCellera Biologics is stepping onto Regeneron’s turf, putting down $90 million in cash to buy out Trianni and its humanized mouse technology for developing antibodies.